Outcomes of single- and two-stage revision total knee arthroplasty for chronic periprosthetic joint infection

医学 假体周围 生存曲线 外科 队列 关节置换术 比例危险模型 内科学 回顾性队列研究 阶段(地层学) 癌症 生物 古生物学
作者
Hosam E. Matar,Benjamin V. Bloch,S. Snape,Peter James
出处
期刊:The bone & joint journal [British Editorial Society of Bone & Joint Surgery]
卷期号:103-B (8): 1373-1379 被引量:41
标识
DOI:10.1302/0301-620x.103b8.bjj-2021-0224.r1
摘要

Aims Single-stage revision total knee arthroplasty (rTKA) is gaining popularity in treating chronic periprosthetic joint infections (PJIs). We have introduced this approach to our clinical practice and sought to evaluate rates of reinfection and re-revision, along with predictors of failure of both single- and two-stage rTKA for chronic PJI. Methods A retrospective comparative cohort study of all rTKAs for chronic PJI between 1 April 2003 and 31 December 2018 was undertaken using prospective databases. Patients with acute infections were excluded; rTKAs were classified as single-stage, stage 1, or stage 2 of two-stage revision. The primary outcome measure was failure to eradicate or recurrent infection. Variables evaluated for failure by regression analysis included age, BMI, American Society of Anesthesiologists grade, infecting organisms, and the presence of a sinus. Patient survivorship was also compared between the groups. Results A total of 292 consecutive first-time rTKAs for chronic PJI were included: 82 single-stage (28.1%); and 210 two-stage (71.9%) revisions. The mean age was 71 years (27 to 90), with 165 females (57.4%), and a mean BMI of 30.9 kg/m 2 (20 to 53). Significantly more patients with a known infecting organism were in the single-stage group (93.9% vs 80.47%; p = 0.004). The infecting organism was identified preoperatively in 246 cases (84.2%). At a mean follow-up of 6.3 years (2.0 to 17.6), the failure rate was 6.1% in the single-stage, and 12% in the two-stage groups. All failures occurred within four years of treatment. The presence of a sinus was an independent risk factor for failure (odds ratio (OR) 4.97; 95% confidence interval (CI) 1.593 to 15.505; p = 0.006), as well as age > 80 years (OR 5.962; 95% CI 1.156 to 30.73; p = 0.033). The ten-year patient survivorship rate was 72% in the single-stage group compared with 70.5% in the two-stage group. This difference was not significant (p = 0.517). Conclusion Single-stage rTKA is an effective strategy with a high success rate comparable to two-stage approach in appropriately selected patients. Cite this article: Bone Joint J 2021;103-B(8):1373–1379.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
dracovu发布了新的文献求助10
1秒前
健康乐悠悠完成签到 ,获得积分10
4秒前
Tiantian完成签到 ,获得积分10
5秒前
Lucas应助otto12306采纳,获得10
7秒前
8秒前
开心的盼波完成签到 ,获得积分10
9秒前
11秒前
cepha完成签到 ,获得积分10
12秒前
忧虑的靖巧完成签到 ,获得积分0
12秒前
在下小李发布了新的文献求助10
15秒前
木卫二完成签到 ,获得积分10
16秒前
Liumingyu发布了新的文献求助10
17秒前
22秒前
YuLu完成签到 ,获得积分10
24秒前
清风细雨完成签到 ,获得积分10
25秒前
灯座完成签到,获得积分10
27秒前
Liumingyu完成签到,获得积分10
27秒前
小肚黄完成签到 ,获得积分10
28秒前
otto12306发布了新的文献求助10
29秒前
壮观的谷冬完成签到 ,获得积分0
29秒前
32秒前
lyra1111完成签到,获得积分10
37秒前
圈圈完成签到,获得积分10
38秒前
Tasia完成签到 ,获得积分10
45秒前
Kelly完成签到,获得积分10
45秒前
sonicker完成签到 ,获得积分10
47秒前
惜缘完成签到 ,获得积分10
47秒前
51秒前
朱大帅发布了新的文献求助10
54秒前
lgy完成签到 ,获得积分10
56秒前
潇洒慕蕊完成签到 ,获得积分10
59秒前
易瑾完成签到 ,获得积分10
1分钟前
lulu完成签到,获得积分10
1分钟前
LYT完成签到 ,获得积分10
1分钟前
风雨晴鸿完成签到 ,获得积分10
1分钟前
收集快乐完成签到 ,获得积分10
1分钟前
qq完成签到 ,获得积分0
1分钟前
林读书完成签到 ,获得积分10
1分钟前
cdercder应助科研通管家采纳,获得10
1分钟前
英姑应助科研通管家采纳,获得10
1分钟前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
久松真一著作集〈第5巻〉禅と芸術 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6554154
求助须知:如何正确求助?哪些是违规求助? 8339033
关于积分的说明 17864821
捐赠科研通 5670703
什么是DOI,文献DOI怎么找? 2939899
邀请新用户注册赠送积分活动 1915770
关于科研通互助平台的介绍 1785125